| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.4 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.073 | 0.4 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |